Overview

Safety Study of Olopatadine Nasal Spray

Status:
Completed

Trial end date:
2008-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether olopatadine nasal spray is safe and effective when used for up to one year by patients with perennial allergic rhinitis.

Phase:

Phase 3

Details

Lead Sponsor:

Alcon Research

Treatments:

Olopatadine Hydrochloride